Latest Stories from Pharmaceuticalsdlvr.it Promoted Storieshttps://static.dlvr.it/images/d.pnghttps://static.dlvr.it/images/favicon.icotag:news.dlvr.it,2015-04-13:/category/medical/pharmaceuticals2015-04-13T06:11:51-07:00<![CDATA[Genzyme to Present New Long-Term Data on Aubagio® (teriflunomide) and Lemtrada® (alemtuzumab) at AAN]]>tag:news.dlvr.it,2015-04-13:3669392015-04-13T06:05:42-07:00
– 30 Presentations Planned On Marketed Products and New Data from
Company’s MS Pipeline –
]]><![CDATA[Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter 2015 Financial Results on April 30, 2015]]>tag:news.dlvr.it,2015-04-13:3606912015-04-13T06:01:32-07:00]]><![CDATA[Clavicle Fractures: When to Fix]]>tag:news.dlvr.it,2015-04-13:3549992015-04-13T06:01:01-07:00BroadcastMed, Inc. and New England Baptist Hospital present Dr. Paul Weitzel and his presentation on current thinking of when and how to fix mid-shaft, lateral third and medial clavicle fractures.]]><![CDATA[John Winkelman, M.D., Ph.D., Joins Flex Pharma’s Scientific Advisory Board]]>tag:news.dlvr.it,2015-04-13:3653392015-04-13T05:31:02-07:00]]><![CDATA[Zoetis Appoints Paul M. Bisaro to Board of Directors]]>tag:news.dlvr.it,2015-04-13:3575392015-04-13T05:30:55-07:00Zoetis Inc. today announced that its Board of Directors has appointed Paul M. Bisaro, Executive Chairman of Actavis plc, to the company’s Board of Directors.]]><![CDATA[Hydra Biosciences and Boehringer Ingelheim Enter Research Collaboration Focused on Renal Diseases and Disorders]]>tag:news.dlvr.it,2015-04-13:3726172015-04-13T05:07:21-07:00Hydra Biosciences, Inc., a leader in the field of transient receptor potential channel modulation, and Boehringer Ingelheim announced that they have entered into a worldwide research collaboration.]]><![CDATA[Uptravi Boost to Pulmonary Arterial Hypertension (PAH) Market to Be Game Changer: Transparency Market Research]]>tag:news.dlvr.it,2015-04-13:3570482015-04-13T05:06:12-07:00Pulmonary Arterial Hypertension (PAH) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020]]><![CDATA[Eagle Pharmaceuticals Appoints David M. Pernock to Its Board of Directors]]>tag:news.dlvr.it,2015-04-13:3553512015-04-13T05:06:06-07:00]]><![CDATA[Hydra Biosciences and Boehringer Ingelheim Enter Research Collaboration Focused on Renal Diseases and Disorders]]>tag:news.dlvr.it,2015-04-13:3694342015-04-13T05:05:47-07:00]]><![CDATA[Critical Path Institute Secures Regulatory Support for Skeletal Muscle Safety Biomarkers]]>tag:news.dlvr.it,2015-04-13:3713812015-04-13T05:04:22-07:00
FDA and EMA Letters of Support Suggest Valuable Research Potential
]]><![CDATA[Paolo Paoletti, M.D., Named To FORMA Therapeutics Board of Directors]]>tag:news.dlvr.it,2015-04-13:3630212015-04-13T05:04:08-07:00FORMA appointed Paolo Paoletti, M.D., to its Board of Directors. He will also lead FORMA's Research & Development Committee as its chairperson. Dr. Paoletti was previously President of GSK Oncology.]]><![CDATA[PatientsLikeMe and AstraZeneca Announce Global Research Collaboration]]>tag:news.dlvr.it,2015-04-13:3578252015-04-13T05:01:13-07:00
Five-Year Agreement Focused on Improving Health Outcomes for Patients
Across Main Therapy Areas
]]><![CDATA[Ichor Medical Systems Announces Strategic Collaboration with Johnson & Johnson Innovation to Develop and Commercialize Immunotherapies Delivered with TriGrid Electroporation Device for Chronic Hepatitis B]]>tag:news.dlvr.it,2015-04-13:3667832015-04-13T05:00:57-07:00]]><![CDATA[MPM Capital Appoints Gregory Sieczkiewicz as Managing Director and Chief Counsel – Intellectual Property]]>tag:news.dlvr.it,2015-04-13:3592872015-04-13T05:00:50-07:00
-Experienced VC patent expert to provide IP counsel-
]]><![CDATA[Arrowhead Cleared to Proceed with Multiple Dose Phase 2b Study of ARC-520]]>tag:news.dlvr.it,2015-04-13:3717272015-04-13T04:30:25-07:00Arrowhead Research Corporation announced that the United States Food and Drug Administration (FDA) informed the Company that it can proceed with a multiple-dose Phase 2b clinical study of ARC-520]]>
– 30 Presentations Planned On Marketed Products and New Data from
Company’s MS Pipeline –
]]>
]]>
BroadcastMed, Inc. and New England Baptist Hospital present Dr. Paul Weitzel and his presentation on current thinking of when and how to fix mid-shaft, lateral third and medial clavicle fractures.]]>
]]>
Zoetis Inc. today announced that its Board of Directors has appointed Paul M. Bisaro, Executive Chairman of Actavis plc, to the company’s Board of Directors.]]>
Hydra Biosciences, Inc., a leader in the field of transient receptor potential channel modulation, and Boehringer Ingelheim announced that they have entered into a worldwide research collaboration.]]>
Pulmonary Arterial Hypertension (PAH) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020]]>
]]>
FDA and EMA Letters of Support Suggest Valuable Research Potential
]]>
FORMA appointed Paolo Paoletti, M.D., to its Board of Directors. He will also lead FORMA's Research & Development Committee as its chairperson. Dr. Paoletti was previously President of GSK Oncology.]]>
Five-Year Agreement Focused on Improving Health Outcomes for Patients
Across Main Therapy Areas
]]>
]]>
-Experienced VC patent expert to provide IP counsel-
]]>
Arrowhead Research Corporation announced that the United States Food and Drug Administration (FDA) informed the Company that it can proceed with a multiple-dose Phase 2b clinical study of ARC-520]]>